Resultado de búsqueda
6 de feb. de 2014 · A total of forty-one volunteers underwent an ultrasound (US) scan of the distal antero-medial thigh in order to investigate the architecture of the vastus medialis oblique. Approval for this research was obtained from the local Research Ethics Committee.
- PubMed
Background: A commonly cited theory related to the...
- PubMed
Abstract. [Purpose] This report describes an unusual incidental finding during ultrasound investigation of the vastus medialis muscle. Volunteers underwent ultrasound scanning as part of an on-going investigation into the architecture of the vastus medialis muscle.
Background: A commonly cited theory related to the pathomechanics of patellofemoral pain (PFP) states that atrophy of the vastus medialis (VM) muscle leads to lateral tracking of the patella. However, isolated atrophy of the VM or atrophy of the quadriceps muscle group as a whole, has not been consistently reported in this population.
RESUMEN: Los estudios anatómicos describen que el músculo vasto medial (VM) se subdivide en dos componentes morfológicamente distintos, el vasto medial obliquus (VMO) y el vasto medial largo (VML). Sin embargo, existen discrepancias con respecto a la diferenciación funcional de estos componentes.
1 de ago. de 2016 · This study examined the contribution of muscle fiber orientation at different knee angles to regional activation identified with high-density surface electromyography (HDsEMG). Monopolar HDsEMG signals were collected using a grid of 13 × 5 electrodes placed over the vastus medialis (VM).
We compared maximal cross-sectional area of the vastus medialis on SPECT-CT for difference of bilateral lower limbs. We also analyzed the relationship between volume of vastus medialis and scintigraphic uptake measured on SPECT-CT and the severity of OA on conventional radiographs.
The vastus medialis oblique (VMO) muscle is reported to be the primary stabilizer of the patella during knee extension. Most studies and treatment protocols emphasize strengthening of the VMO as the nonsurgical treatment of choice for patients with PF)D.
